Drug intelligence / Profile preview

Compound Houttuynia Tablets

Development stage: Unknown
Lead developer: Jilin Fukang Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Compound Houttuynia Tablets is a traditional Chinese medicine (TCM) oral formulation developed and manufactured by Jilin Fukang Pharmaceutical. It is a multi-ingredient herbal preparation primarily composed of *Houttuynia cordata* (Yuxingcao), supplemented with other botanical extracts including *Scutellaria baicalensis* (Huangqin), *Forsythia suspensa* (Lianqiao), *Isatis tinctoria* (Banlangen), and *Lonicera japonica* (Jinyinhua). The drug is indicated for clearing heat and detoxifying the body, specifically for the treatment of respiratory conditions such as acute tonsillitis, pharyngitis, and upper respiratory tract infections. Its therapeutic effects are attributed to the synergistic action of various phytochemicals, such as decanoyl acetaldehyde (houttuynin) and baicalin, which exhibit broad-spectrum antimicrobial, antiviral, and anti-inflammatory properties.

Brand names: Compound Houttuynia Tablets
Other names: Fufang Yuxingcao PianCompound Houttuynia Cordata Tablets复方鱼腥草片

Targets

JUN (Transcription factor Jun)IL-6 (Interleukin 6)MMP9 (Matrix metalloproteinase-9)VEGFA (Vascular endothelial growth factor A)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)EGFR T790M (Epidermal growth factor receptor T790M mutant)MMP1 (Matrix metalloproteinase-1)

Beyond the preview

Go deeper on Compound Houttuynia Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compound Houttuynia Tablets.

Explore the full profile